Viewing Study NCT00226668

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-05-12 @ 11:06 PM
Study NCT ID: NCT00226668
Status: WITHDRAWN
Last Update Posted: 2008-01-03
First Post: 2005-09-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
Sponsor: Celtic Pharma Development Services
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain Edema View
None Brain Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None peritumoral brain edema View
None edema View
None malignant brain tumor View
None astrocytoma View
None brain tumor View
None dexamethasone View
None Decadron View